BRPI0510397A - compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmos - Google Patents
compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmosInfo
- Publication number
- BRPI0510397A BRPI0510397A BRPI0510397-5A BRPI0510397A BRPI0510397A BR PI0510397 A BRPI0510397 A BR PI0510397A BR PI0510397 A BRPI0510397 A BR PI0510397A BR PI0510397 A BRPI0510397 A BR PI0510397A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- methods
- compositions containing
- pharmaceutical compositions
- same
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57463904P | 2004-05-26 | 2004-05-26 | |
| PCT/US2005/018443 WO2005117590A2 (en) | 2004-05-26 | 2005-05-25 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0510397A true BRPI0510397A (pt) | 2007-11-13 |
Family
ID=35463277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0510397-5A BRPI0510397A (pt) | 2004-05-26 | 2005-05-25 | compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090005435A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1758577A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008500363A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20070095754A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101022792A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005249437A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0510397A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2568639A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL179530A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06013687A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2006146051A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005117590A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200700024B (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007014248A2 (en) * | 2005-07-26 | 2007-02-01 | Johns Hopkins University | Method of reducing food intake |
| AU2007300627B2 (en) * | 2006-09-22 | 2012-02-16 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
| KR101640263B1 (ko) * | 2007-10-05 | 2016-07-15 | 젠자임 코포레이션 | 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법 |
| WO2010118324A2 (en) | 2009-04-09 | 2010-10-14 | Nuclea Biotechnologies, LLC | Antibodies against fatty acid synthase |
| WO2014039769A1 (en) * | 2012-09-07 | 2014-03-13 | Janssen Pharmaceutica Nv | Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer |
| CA2968288A1 (en) | 2014-11-20 | 2016-05-26 | Vib Vzw | Means and methods for treatment of early-onset parkinson's disease |
| CN114980740A (zh) | 2020-01-23 | 2022-08-30 | 巴斯夫欧洲公司 | 用于农业化学配制剂的新型添加剂 |
| CN116507203B (zh) | 2020-10-27 | 2026-08-07 | 巴斯夫欧洲公司 | 农药微乳剂组合物 |
| CA3207197A1 (en) | 2021-02-05 | 2022-08-11 | Murat Mertoglu | Liquid herbicidal compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3427847A1 (de) * | 1983-12-09 | 1985-06-13 | Bayer Ag, 5090 Leverkusen | Thiolan-2,4-dion-3-carboxamide |
| US5759837A (en) * | 1989-01-17 | 1998-06-02 | John Hopkins University | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway |
| US5614551A (en) * | 1994-01-24 | 1997-03-25 | The Johns Hopkins University | Inhibitors of fatty acid synthesis as antimicrobial agents |
| US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
| MXPA04007556A (es) * | 2002-02-08 | 2005-12-05 | Univ Johns Hopkins Med | Estimulacion de cpt-1 como medio para reducir peso. |
| US7649012B2 (en) * | 2002-07-09 | 2010-01-19 | Fasgen, Inc. | Compounds, pharmaceutical compositions containing same, and methods of use for same |
-
2005
- 2005-05-25 CN CNA2005800233119A patent/CN101022792A/zh active Pending
- 2005-05-25 CA CA002568639A patent/CA2568639A1/en not_active Abandoned
- 2005-05-25 JP JP2007515318A patent/JP2008500363A/ja active Pending
- 2005-05-25 WO PCT/US2005/018443 patent/WO2005117590A2/en not_active Ceased
- 2005-05-25 KR KR1020067026941A patent/KR20070095754A/ko not_active Withdrawn
- 2005-05-25 ZA ZA200700024A patent/ZA200700024B/en unknown
- 2005-05-25 BR BRPI0510397-5A patent/BRPI0510397A/pt not_active IP Right Cessation
- 2005-05-25 EP EP05754100A patent/EP1758577A4/en not_active Withdrawn
- 2005-05-25 RU RU2006146051/04A patent/RU2006146051A/ru not_active Application Discontinuation
- 2005-05-25 MX MXPA06013687A patent/MXPA06013687A/es not_active Application Discontinuation
- 2005-05-25 US US11/597,538 patent/US20090005435A1/en not_active Abandoned
- 2005-05-25 AU AU2005249437A patent/AU2005249437A1/en not_active Abandoned
-
2006
- 2006-11-23 IL IL179530A patent/IL179530A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005117590A3 (en) | 2006-07-27 |
| WO2005117590A2 (en) | 2005-12-15 |
| ZA200700024B (en) | 2008-06-25 |
| JP2008500363A (ja) | 2008-01-10 |
| AU2005249437A1 (en) | 2005-12-15 |
| RU2006146051A (ru) | 2008-07-10 |
| EP1758577A2 (en) | 2007-03-07 |
| US20090005435A1 (en) | 2009-01-01 |
| EP1758577A4 (en) | 2010-05-05 |
| CA2568639A1 (en) | 2005-12-15 |
| IL179530A0 (en) | 2007-05-15 |
| MXPA06013687A (es) | 2007-10-18 |
| CN101022792A (zh) | 2007-08-22 |
| KR20070095754A (ko) | 2007-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309534A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BR0111754A (pt) | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica | |
| BRPI0512659A (pt) | compostos quìmicos | |
| AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
| BR0208678A (pt) | Composto, composição farmacêutica, uso de um composto | |
| BRPI0507495A (pt) | composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
| BRPI0416004A (pt) | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método para o tratamento de doenças mediadas por glk, uso de um composto ou um sal, solvato ou pró-droga do mesmo, métodos para o tratamento combinado de obesidade e diabetes e para o tratamento de obesidade, e, processo para a preparação de um composto ou um sal, pró-droga ou solvato do mesmo | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| BR0010520A (pt) | Novos compostos farmaceuticamente ativos | |
| BRPI0412659A (pt) | isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto | |
| BR0211427A (pt) | Compostos, processo para preparar os mesmos, composição adequada para combater fungos danosos, uso de compostos, e, processo para combater fungos danosos | |
| BR0008763A (pt) | Derivados de piridopiranoazepinas, a preparação dos mesmos e a respectiva aplicação em terapêutica | |
| BRPI0806789B8 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| BRPI0416039A (pt) | derivados de tiazol e pirazol como inibidores de flt-3 cinase | |
| BRPI0417161A (pt) | compostos, composições farmacêuticas, e, uso de um composto | |
| ATE503746T1 (de) | Neue imidazolidinderivate | |
| ATE482933T1 (de) | Sulfopyrrolderivate | |
| BR0212353A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| ATE453389T1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| BR0213465A (pt) | Compostos de 4-imidazolin-2-ona | |
| BR0004534A (pt) | Composto, composição farmacêutica, agente contendo um composto, e uso de um composto. | |
| BRPI0506718A (pt) | compostos, processo de preparação dos mesmos, e, composição farmacêutica ou cosmética | |
| BRPI0508102A (pt) | inibidores de caspase e usos dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |